The Use of Tinted Spectacle Lenses to Treat Positive Dysphotopsia after IOL Implantation: A Case Report
Journal of Ophthalmic and Optometric Sciences · 23.09.2023
DOI: 10.22037/joos.v7i4.47447 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Ophthalmic and Optometric Sciences, erschienen am 23.09.2023. Verfasst von Alireza Sadeghi und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Purpose
To report a case of positive dysphotopsia (PD) following intraocular lens (IOL) implantation.Case Report: A 57-year-old male presented with significant PD symptoms, including photophobia and glare, after monofocal IOL implantation. Despite treatment with artificial tears and corticosteroids, the patient continued to experience visual discomfort, requiring sunglasses even indoors. He was prescribed brown-tinted lenses with 40 % tint. After one month of use, the patient reported substantial improvement in PD symptoms, increased contrast sensitivity, and cosmetic satisfaction.
Conclusion
Tinted spectacle lenses provide a non-invasive option for managing persistent PD. In our case, brown-tinted lenses effectively reduced glare and enhanced visual comfort. Further studies are needed to investigate the broader role of tinted lenses in managing visual disturbances associated with IOL implantation.
Schlagwörter
Zitieren
APA
Sadeghi, A., Moravej, R., & Khabazkhoob, M. (2023). The Use of Tinted Spectacle Lenses to Treat Positive Dysphotopsia after IOL Implantation: A Case Report. Journal of Ophthalmic and Optometric Sciences. https://doi.org/10.22037/joos.v7i4.47447
Vancouver
Sadeghi A, Moravej R, Khabazkhoob M. The Use of Tinted Spectacle Lenses to Treat Positive Dysphotopsia after IOL Implantation: A Case Report. Journal of Ophthalmic and Optometric Sciences. 2023. doi:10.22037/joos.v7i4.47447
BibTeX
@article{Sadeghi2023,
author = {Sadeghi, Alireza and Moravej, Raheleh and Khabazkhoob, Mehdi},
title = {The Use of Tinted Spectacle Lenses to Treat Positive Dysphotopsia after IOL Implantation: A Case Report},
journal = {Journal of Ophthalmic and Optometric Sciences},
year = {2023},
doi = {10.22037/joos.v7i4.47447}
}
EUVIMED